Biocompatible nanoadhesive offers hope for safer corneal transplants, reducing inflammation and infection risks
A research team from the Eye & ENT Hospital of Fudan University, China, has developed a novel biocompatible nanoadhesive for ...
FierceBiotech9h
Eli Lilly inks duo of deals, teaming with AdvanCell, OliX to push deeper into radiopharma, MASH
Eli Lilly has begun the week with a bang. Early Monday morning, AdvanCell and OliX Pharmaceuticals put out news that the Big ...
Hosted on MSN1mon
Nucleic acid drug iSN40 shows promise for osteoporosis treatment
This inhibition resulted in a significant reduction ... "With the potential to be used as a nucleic acid-based therapeutic, iSN40 could become an essential tool in addressing the growing ...
The Scientist1mon
Great Anticancer Potential Comes in a Small Package
Her team recently developed a small nanocarrier that actively delivers a poly (ADP-ribose) polymerase (PARP) inhibitor and a demethyltransferase ... or therapeutic nucleic acids. It is fascinating ...
BioWorld5d
Akribion harnessing G-dase E nuclease, with initial focus in cancer
Newco Akribion Therapeutics GmbH has raised €8 million (US$8.3 million) in a seed round to develop a new and potent class of RNA-targeted CRISPR nucleases, which, rather than cleaving specific nucleic ...
Nature3d
Target identification articles from across Nature Portfolio
Target identification is the process of identifying the direct molecular target – for example protein or nucleic acid – of a small ... highly selective kinase inhibitors remains challenging.
Nature10y
Design of angiotensin converting enzyme inhibitors
5) and to study its enzymatic properties, and soon thereafter, Miguel Ondetti and I began a fruitful collaborative effort to discover or design potent and specific inhibitors of ACE. The modern ...